The pharmaceutical industry is largely to blame for the current situation in the US with the increased price pressure and political focus on the sector, believes Jesper Høiland, former VP of Novo Nordisk and currently President and CEO of US Radius Health. He predicts that the "freedom of pricing" will not exist in 5-10 years.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.